第一作者单位：[1]Beijing Friendship Hospital, Beijing, China
推荐引用方式(GB/T 7714)：
Wang Jingshi,Wang Zhao.Multicenter Study of Ruxolitinibcombined DEP Regimen As a Salvage Therapy for Refractory/Relapsed Hemophagocytic Lymphohistiocytosis[J].BLOOD.2019,134:doi:10.1182/blood-2019-130980.
APA：
Wang, Jingshi&Wang, Zhao.(2019).Multicenter Study of Ruxolitinibcombined DEP Regimen As a Salvage Therapy for Refractory/Relapsed Hemophagocytic Lymphohistiocytosis.BLOOD,134,
MLA：
Wang, Jingshi,et al."Multicenter Study of Ruxolitinibcombined DEP Regimen As a Salvage Therapy for Refractory/Relapsed Hemophagocytic Lymphohistiocytosis".BLOOD 134.(2019)
医学